• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺切除术后刺激甲状腺球蛋白水平是复发性/持续性甲状腺乳头状癌再次颈淋巴结清扫术后生化完全缓解的重要预测指标。

Postablation stimulated thyroglobulin level is an important predictor of biochemical complete remission after reoperative cervical neck dissection in persistent/recurrent papillary thyroid carcinoma.

机构信息

Department of Surgery, The University of Hong Kong, Hong Kong SAR, China.

出版信息

Ann Surg Oncol. 2013 Feb;20(2):653-9. doi: 10.1245/s10434-012-2624-8. Epub 2012 Sep 7.

DOI:10.1245/s10434-012-2624-8
PMID:22956067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3560939/
Abstract

BACKGROUND

The efficacy of reoperative cervical neck dissection (RND) in achieving biochemical complete remission (BCR) (or postreoperation stimulated thyroglobulin [sTg] of <0.5 ng/mL) remains unclear in persistent/recurrent papillary thyroid carcinoma (PTC). We hypothesized that lower postablation sTg levels would indicate a higher rate of BCR after RND. Our study examined the association between postablation sTg and BCR after one or more RNDs.

METHODS

Of 199 patients who underwent RND, 81 patients were eligible. The postablation sTg levels (≤2 and >2 ng/mL) were correlated with the postreoperation sTg levels after RNDs. Patients' clinicopathological characteristics, operative findings, and subsequent RNDs were compared between those with BCR after RNDs and those without.

RESULTS

Those with postablation sTg levels of ≤2 ng/mL had significantly higher BCR rate after the first RND (77.8 vs. 5.6 %, p < 0.001), overall BCR after one or more RNDs (77.8 vs. 9.3 %, p < 0.001), and better 5-year recurrence-free survival after the first RND (80.0 vs. 60.1 %, p = 0.049) than those with postablation sTg levels of >2 ng/mL. Overall BCR gradually decreased after each subsequent RND. Postablation sTg significantly correlated with postreoperation sTg (ρ = 0.509, p < 0.001). After adjusting for the number of metastatic lymph nodes excised at first RND and presence of extranodal extension, postablation sTg of ≤ 0.2 ng/mL was the only independent factor for BCR after one or more RNDs (odds ratio 37.0, 95 % confidence interval 5.68-250.0, p = 0.001).

CONCLUSIONS

Only a third of patients who underwent one or more RNDs for persistent/recurrent PTC had BCR afterward. Postablation sTg level was an independent factor for BCR. Completeness of the initial operation is important for the subsequent success of RND.

摘要

背景

在持续性/复发性甲状腺乳头状癌(PTC)中,再次颈淋巴结清扫术(RND)达到生化完全缓解(BCR)(或术后刺激甲状腺球蛋白[sTg]<0.5ng/mL)的疗效尚不清楚。我们假设,消融后 sTg 水平越低,RND 后达到 BCR 的比例越高。本研究检测了 RND 后消融后 sTg 与 BCR 之间的相关性。

方法

在接受 RND 的 199 例患者中,有 81 例符合条件。比较 RND 后消融后 sTg 水平(≤2ng/mL 和>2ng/mL)与 RND 后术后 sTg 水平的相关性。比较 RND 后达到 BCR 与未达到 BCR 的患者的临床病理特征、手术结果和随后的 RND。

结果

在第一次 RND 后,消融后 sTg 水平≤2ng/mL 的患者 BCR 率显著更高(77.8%比 5.6%,p<0.001),总体上,一次或多次 RND 后达到 BCR 的患者比例更高(77.8%比 9.3%,p<0.001),第一次 RND 后 5 年无复发生存率更好(80.0%比 60.1%,p=0.049)。消融后 sTg 水平与术后 sTg 水平显著相关(ρ=0.509,p<0.001)。在调整了首次 RND 切除的转移性淋巴结数量和有无外侵犯后,消融后 sTg 水平≤0.2ng/mL 是一次或多次 RND 后达到 BCR 的唯一独立因素(比值比 37.0,95%置信区间 5.68-250.0,p=0.001)。

结论

只有三分之一的接受一次或多次 RND 治疗持续性/复发性 PTC 的患者在随后达到了 BCR。消融后 sTg 水平是 BCR 的一个独立因素。初始手术的完整性对 RND 后的后续成功至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/077b/3560939/3350b62c06a3/10434_2012_2624_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/077b/3560939/f232de29fae4/10434_2012_2624_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/077b/3560939/3350b62c06a3/10434_2012_2624_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/077b/3560939/f232de29fae4/10434_2012_2624_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/077b/3560939/3350b62c06a3/10434_2012_2624_Fig2_HTML.jpg

相似文献

1
Postablation stimulated thyroglobulin level is an important predictor of biochemical complete remission after reoperative cervical neck dissection in persistent/recurrent papillary thyroid carcinoma.甲状腺切除术后刺激甲状腺球蛋白水平是复发性/持续性甲状腺乳头状癌再次颈淋巴结清扫术后生化完全缓解的重要预测指标。
Ann Surg Oncol. 2013 Feb;20(2):653-9. doi: 10.1245/s10434-012-2624-8. Epub 2012 Sep 7.
2
Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.甲状腺乳头状癌全甲状腺切除术后预防性和治疗性中央区淋巴结清扫对刺激前甲状腺球蛋白水平的影响。
Ann Surg Oncol. 2012 Jan;19(1):60-7. doi: 10.1245/s10434-011-1833-x. Epub 2011 Jun 17.
3
Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.全甲状腺切除术联合治疗性中央区和侧颈部清扫术加单次剂量放射性碘治疗局部晚期乳头状甲状腺癌的疗效及对血清甲状腺球蛋白的影响
Ann Surg Oncol. 2014 May;21(5):1647-52. doi: 10.1245/s10434-013-3467-7. Epub 2014 Jan 3.
4
Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma.甲状腺癌预防性单侧中央区颈清扫术后刺激后甲状腺球蛋白水平与淋巴结转移大小的关系。
Ann Surg Oncol. 2012 Oct;19(11):3472-8. doi: 10.1245/s10434-012-2385-4. Epub 2012 May 8.
5
Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.消融术前刺激甲状腺球蛋白比淋巴结比率更能预测病理N1a期甲状腺乳头状癌的复发。
Int J Clin Oncol. 2016 Oct;21(5):862-868. doi: 10.1007/s10147-016-0956-2. Epub 2016 Feb 2.
6
Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.转移性乳头状甲状腺癌的结外侵犯:与生化指标、淋巴结残留及全身疾病进展的相关性
Thyroid. 2013 Sep;23(9):1099-105. doi: 10.1089/thy.2013.0027.
7
Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.复发性甲状腺乳头状癌的再次淋巴结清扫术及其对血清甲状腺球蛋白的影响。
Ann Surg Oncol. 2012 Sep;19(9):2951-7. doi: 10.1245/s10434-012-2380-9. Epub 2012 Apr 24.
8
Baseline stimulated thyroglobulin level as a good predictor of successful ablation after adjuvant radioiodine treatment for differentiated thyroid cancers.基线刺激甲状腺球蛋白水平可作为分化型甲状腺癌辅助放射性碘治疗后成功消融的良好预测指标。
Asian Pac J Cancer Prev. 2014;15(15):6443-7. doi: 10.7314/apjcp.2014.15.15.6443.
9
Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection.预防性单侧中央区颈清扫术后刺激甲状腺球蛋白水平与甲状腺乳头状癌转移性淋巴结比率的意义。
Ann Surg Oncol. 2012 Apr;19(4):1257-63. doi: 10.1245/s10434-011-2105-5. Epub 2011 Oct 12.
10
Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation.对于初始接受全甲状腺切除术和大剂量残留消融术的患者,局部区域性复发性甲状腺乳头状癌再手术后的辅助放射性治疗。
J Clin Endocrinol Metab. 2011 Dec;96(12):3695-700. doi: 10.1210/jc.2011-1270. Epub 2011 Oct 5.

引用本文的文献

1
Recurrent Papillary Thyroid Carcinoma to the Cervical Lymph Nodes: Outcomes of Compartment-Oriented Lymph Node Resection.复发性甲状腺乳头状癌颈部淋巴结转移:基于分区的淋巴结切除术的疗效。
World J Surg. 2019 Nov;43(11):2842-2849. doi: 10.1007/s00268-019-05094-9.
2
The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER.放射性碘治疗在甲状腺乳头状癌中的作用:一项基于监测、流行病学和最终结果(SEER)数据库的观察性研究
Onco Targets Ther. 2018 Jun 19;11:3551-3560. doi: 10.2147/OTT.S160752. eCollection 2018.
3
Bioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancer.

本文引用的文献

1
Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?未受刺激的甲状腺球蛋白速度在放射性碘消融后可检测到甲状腺球蛋白的甲状腺乳头状癌患者中预测复发是否有作用?
Ann Surg Oncol. 2012 Oct;19(11):3479-85. doi: 10.1245/s10434-012-2391-6. Epub 2012 May 11.
2
Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.复发性甲状腺乳头状癌的再次淋巴结清扫术及其对血清甲状腺球蛋白的影响。
Ann Surg Oncol. 2012 Sep;19(9):2951-7. doi: 10.1245/s10434-012-2380-9. Epub 2012 Apr 24.
3
甲状腺癌中潜在预后性微小RNA和信使核糖核酸的生物信息学分析与鉴定
PeerJ. 2018 May 4;6:e4674. doi: 10.7717/peerj.4674. eCollection 2018.
4
Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.局部复发性/持续性乳头状甲状腺癌首次再次手术后复发的危险因素
World J Surg. 2015 Aug;39(8):1943-50. doi: 10.1007/s00268-015-3052-2.
5
New molecular targeted therapy and redifferentiation therapy for radioiodine-refractory advanced papillary thyroid carcinoma: literature review.放射性碘难治性晚期乳头状甲状腺癌的新型分子靶向治疗与再分化治疗:文献综述
J Thyroid Res. 2012;2012:818204. doi: 10.1155/2012/818204. Epub 2012 Dec 24.
The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies.
预防性中央区颈部清扫术在分化型甲状腺癌中的作用:问题与争议。
J Oncol. 2011;2011:127929. doi: 10.1155/2011/127929. Epub 2011 Sep 29.
4
Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.甲状腺乳头状癌全甲状腺切除术后预防性和治疗性中央区淋巴结清扫对刺激前甲状腺球蛋白水平的影响。
Ann Surg Oncol. 2012 Jan;19(1):60-7. doi: 10.1245/s10434-011-1833-x. Epub 2011 Jun 17.
5
Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.甲状腺全切除术后促甲状腺激素抑制治疗下血清甲状腺球蛋白倍增时间对甲状腺乳头状癌患者预后的影响。
Thyroid. 2011 Jul;21(7):707-16. doi: 10.1089/thy.2010.0355. Epub 2011 Jun 7.
6
The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation.初次全甲状腺切除及残余组织消融术后局部区域复发性/持续性甲状腺乳头状癌患者再次手术的结果。
J Clin Endocrinol Metab. 2011 Jul;96(7):2049-56. doi: 10.1210/jc.2010-2298. Epub 2011 Apr 20.
7
Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin.用基础血清甲状腺球蛋白的敏感测量来评估分化型甲状腺癌的风险适应管理。
J Clin Endocrinol Metab. 2011 Jun;96(6):1703-9. doi: 10.1210/jc.2010-2695. Epub 2011 Mar 30.
8
Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer.淋巴结再次手术治疗持续性甲状腺乳头状癌的长期疗效。
J Clin Endocrinol Metab. 2010 May;95(5):2187-94. doi: 10.1210/jc.2010-0063. Epub 2010 Mar 23.
9
Diagnostic approach for evaluation of lymph node metastasis from thyroid cancer using ultrasound and fine-needle aspiration biopsy.使用超声和细针穿刺活检评估甲状腺癌淋巴结转移的诊断方法。
AJR Am J Roentgenol. 2010 Jan;194(1):38-43. doi: 10.2214/AJR.09.3128.
10
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.美国甲状腺协会修订的甲状腺结节和分化型甲状腺癌患者管理指南。
Thyroid. 2009 Nov;19(11):1167-214. doi: 10.1089/thy.2009.0110.